---
DISCLAIMER: This guidance is AI-generated based on NASA Systems Engineering
standards. It is advisory only and does not constitute official NASA guidance.
All SE decisions require human review and professional engineering judgment.
Not for use in mission-critical decisions without SME validation.
---

# Technical Review Gate — ADR-001 Test Harness Architecture

> **Project:** PROJ-035-skill-optimization
> **Entry:** e-001
> **Review Type:** CDR (Critical Design Review — architecture decision gate)
> **Review Date:** 2026-03-06
> **Reviewer:** nse-reviewer (Phase 8, Gate B)
> **Input Artifact:** `projects/PROJ-035-skill-optimization/decisions/ADR-001-test-harness-architecture.md`
> **Status:** CONDITIONAL PASS

---

## Document Sections

| Section | Purpose |
|---------|---------|
| [Entrance Criteria Checklist](#entrance-criteria-checklist) | Pre-review gate: format, status, artifact accessibility |
| [Check 1: Requirements Traceability](#check-1-requirements-traceability) | FEAT-035-001 linkage, acceptance criteria coverage |
| [Check 2: Evidence Basis](#check-2-evidence-basis) | Phase 1/3/5 grounding, citation specificity |
| [Check 3: Risk Coverage](#check-3-risk-coverage) | FMEA reference, mitigations, residual risks |
| [Check 4: Implementation Feasibility](#check-4-implementation-feasibility) | Jerry framework constraints, dependency conflicts, roadmap realism |
| [Check 5: Interface Compatibility](#check-5-interface-compatibility) | PROJ-017 ADR-002 alignment, integration conflicts, API boundaries |
| [Exit Criteria Checklist](#exit-criteria-checklist) | Post-review gate: findings complete, blockers cleared |
| [Verdict](#verdict) | PASS / CONDITIONAL PASS / FAIL with rationale |
| [Required Actions](#required-actions) | Specific items required before or after acceptance |
| [References](#references) | NASA sources cited |

---

## L0: Executive Summary

**Readiness:** Conditional Pass

ADR-001 is a well-constructed architecture decision document that demonstrates thorough evidence grounding across six prior research artifacts and correctly identifies the Four-Layer Composite as the architecturally superior option. No Category 1 (blocking) findings were identified. Three Category 2 (significant) findings were identified: a score-matrix discrepancy between ADR and Phase 5, an unresolved Node.js/UV toolchain conflict that lacks a complete fallback path, and an undefined minimum sample size validation strategy for the N >= 20 requirement. All three have documented mitigations within the ADR. Six Category 3 (advisory) findings provide quality improvements but do not block acceptance.

The ADR is ready for human review and acceptance pending acknowledgment of the Category 2 findings.

---

## Entrance Criteria Checklist

| # | Criterion | Status | Evidence | Notes |
|---|-----------|--------|----------|-------|
| E-1 | ADR follows Nygard format (Title, Status, Context, Decision, Consequences) | PASS | ADR lines 1-645: Title present; Status section at line 32; Context (L1: Context) at line 67; Decision (L1: Decision) at line 243; Consequences (L1: Consequences) at line 422 | Full Nygard structure confirmed. ADR extends standard format with L0/L1/L2 sections consistent with Jerry output standards. |
| E-2 | Status is "Proposed" (not "Accepted" — human review required per P-020) | PASS | ADR line 34: "**PROPOSED**"; line 36: "Pending user approval per P-020" | P-020 compliance confirmed. Status will transition to ACCEPTED only upon user confirmation. |
| E-3 | All referenced input artifacts exist and are accessible | PASS with caveat | All six primary input artifacts confirmed present at their stated paths: `research/historical-testing-methodologies.md`, `research/industry-frameworks-survey.md`, `research/agent-sdk-evaluation.md`, `research/innovation-frameworks.md`, `analysis/cross-pollination-synthesis.md`, `analysis/test-harness-evaluation.md`. PROJ-017 ADR-002 confirmed present (ADR-002-quality-framework-selection in PROJ-017-llm-skill-testing). Note: ADR references "PROJ-017 ADR-002" without specifying full path; actual project directory is PROJ-017-llm-skill-testing. This is a documentation precision issue only; the file exists. |

**Entrance Criteria Result: PASS** — All entrance criteria met. Proceed to technical review.

---

## Check 1: Requirements Traceability

### Finding Summary

**Category 3 (Advisory):** Traceability to FEAT-035-001 acceptance criteria is complete but implicit for criterion AC-4.

### Analysis

**1.1 Linkage to FEAT-035-001**

ADR-001 explicitly identifies FEAT-035-001 in its header block (line 4: "`**Feature:** FEAT-035-001`") and in the Status section (line 36: "synthesizes findings from six prior artifacts across Phases 1A, 1B, 1C, 1D, 3, and 5 of the PROJ-035 FEAT-035-001 orchestration pipeline"). Traceability to the originating feature is clear and direct.

**1.2 Acceptance Criteria Coverage**

FEAT-035-001 defines five acceptance criteria. This review assesses each:

| AC # | Acceptance Criterion | ADR Coverage | Status |
|------|---------------------|--------------|--------|
| AC-1 | Research phase produces verified survey (4 deliverables, all externally sourced) | ADR Evidence Traceability table (E-001 through E-020) cites all four Phase 1 artifacts as inputs. The Phase 5 score at revision 2 (0.923) confirms the research artifacts passed quality gate. | PASS |
| AC-2 | Cross-pollination synthesis maps historical methodologies to LLM testing equivalents with framework capability matrix | ADR cites Phase 3 synthesis in six convergence patterns (PAT-001 through PAT-006) and evidence entries E-015/E-016/E-017. The synthesis directly fed the Forces table at ADR lines 81-88. | PASS |
| AC-3 | Analytical evaluation scores candidate approaches across 6 dimensions with FMEA risk analysis | ADR directly adopts the Phase 5 evaluation; the six-dimension Options Comparison Matrix (lines 219-227) and 10-item FMEA risk register (lines 461-472) are both present and sourced to Phase 5. | PASS |
| AC-4 | Architecture Decision Record (ADR-001) recommends test harness architecture with evidence-traced rationale | This ADR is the deliverable for AC-4. The Decision section recommends Option B Four-Layer Composite with five converging evidence lines. AC-4 is satisfied by the existence and quality of this ADR. | PASS |
| AC-5 | All deliverables pass S-014 quality gate (>= 0.92) and NSE technical review | Phase 5 analysis passed at 0.923 (revision 2 score). ADR itself is subject to this gate review. Phases 1A-1D and Phase 3 quality scores are not directly referenced in the ADR — the ADR does not explicitly state whether each Phase 1 research artifact passed the quality gate. | PARTIAL — see Finding R-1 |

**Finding R-1 (Category 3):** The ADR does not explicitly confirm that Phase 1A, 1B, 1C, and 1D research artifacts passed the S-014 quality gate (>= 0.92). Phase 5 passing is confirmed by the adv-scorer report. Phase 3 passing is not referenced. The Phase 1 score reports at `work/test-harness/adv/phase-1-scores/` exist but their verdicts are not surfaced in the ADR's evidence traceability table.

**1.3 Evaluation Dimensions Traceability**

The six evaluation dimensions used in the ADR Options Comparison Matrix (Refactoring Safety, Migration Confidence, Determinism Coverage, Statistical Rigor, Integration Feasibility, Time to First Value) are traceable to stakeholder needs through Forces F-1 through F-6 in the Context section (lines 81-88). Each Force cites Phase 1/3 evidence. The dimension selection is justified, though the ADR uses a different sixth dimension (Time to First Value) than Phase 5 used (Evidence Basis). The ADR acknowledges this discrepancy at line 237: "Note on weight differences from Phase 5." This is transparent but introduces a traceability gap — the dimension change is disclosed but not formally justified against stakeholder need priorities.

**Finding R-2 (Category 3):** The substitution of "Time to First Value" for "Evidence Basis" as the sixth evaluation dimension is disclosed but not traced to a stakeholder requirement or decision authority that approved the dimensional change. This is a methodology transparency issue rather than a blocking deficiency.

### Traceability Check Verdict

PASS with two Category 3 advisory findings. Requirements linkage is complete and the ADR addresses all acceptance criteria. No blocking findings.

---

## Check 2: Evidence Basis

### Finding Summary

**No Category 1 or Category 2 findings.** One Category 3 finding.

### Analysis

**2.1 Grounding in Phase 1/3/5 Evidence**

The ADR contains 21 evidence entries (E-001 through E-021) in the Evidence Traceability table (lines 597-619). Each entry specifies the source artifact and the specific section or location within that artifact. This is a comprehensive evidence chain.

Key evidence citations are verified against the source artifact (Phase 5 evaluation, which was directly read):

| ADR Claim | Citation | Verification |
|-----------|----------|--------------|
| "Four-Layer Composite scored 4.65/5.00" | Phase 5 L1 Comparative Matrix (E-018) | Phase 5 document line 41 confirms "Four-Layer Composite... 4.65/5.00" in L0 Executive Summary. VERIFIED. |
| "10 failure modes" with FM-007 RPN=432 highest | Phase 5 L1 FMEA (E-019) | Phase 5 FMEA section confirmed; FM-007 (O=6, S=9, D=8, RPN=432) verified at Phase 5 lines 251-262. VERIFIED. |
| "LLMORPH: 560,000 tests, 8.6% false positive rate" (ASE 2025) | Phase 1D Innovation #2 (E-010) | Cited verbatim from Phase 5 document which itself quotes this source; traceable. VERIFIED through intermediate citation. |
| "CLT-based methods perform very poorly" (ICML 2025) | Phase 1D Innovation #6 (E-011) | Cited verbatim in Phase 5, innovation-frameworks.md. Confirmed in Phase 5 phase-5-score.md evidence review. VERIFIED through intermediate citation. |
| PROJ-017 ADR-002 recommends promptfoo Extension | E-021 | ADR-002 L0 confirmed: "We recommend Option B: promptfoo Extension" at line 43. VERIFIED directly. |

**2.2 Citation Specificity**

The ADR achieves passage-level citation specificity in its evidence traceability table. Evidence entries include file path and section identifier (e.g., E-003: "Phase 1B: `research/industry-frameworks-survey.md` | L1C Capability Comparison Matrix (statistical rigor row: all LOW)"). This is the same standard applied in Phase 5 Revision 2, which passed evidence quality at 0.89.

**2.3 Claims Without Evidence Support**

A systematic review of the ADR's key claims identified one claim that relies on inference without explicit evidence labeling:

**Finding E-1 (Category 3):** ADR line 219-227 (Options Comparison Matrix) shows Option B scoring 4.45 as its weighted total, while the Phase 5 document (L0 Executive Summary, line 41) states the Four-Layer Composite scored 4.65/5.00. The ADR acknowledges this discrepancy at line 237: "Note on weight differences from Phase 5: This ADR uses a six-dimension evaluation (adding Time to First Value)." However, the ADR does not explicitly demonstrate that the 4.45 score under the ADR's weights is consistent with a 4.65 score under Phase 5's weights, or explain why Option B retains its top-ranked position despite the different scoring methodology. This is an evidence transparency issue, not an evidence fabrication issue — but a reader cannot independently verify that the dimension substitution did not produce an artifact ranking change.

The sensitivity analysis at line 239 partially addresses this by showing Option B leads Option A even at doubled Time to First Value weight, but does not address Option C's position or the Phase 5-to-ADR score mapping.

### Evidence Basis Check Verdict

PASS with one Category 3 finding. All major claims are grounded in Phase 1/3/5 research. Citations are sufficiently specific for verification. No unsupported claims were identified that affect the decision outcome.

---

## Check 3: Risk Coverage

### Finding Summary

**Category 2 (Significant):** N >= 20 sample size requirement creates a validation gap that is acknowledged but lacks a concrete validation strategy.

### Analysis

**3.1 FMEA Reference**

The ADR's L1: Risks section (lines 457-474) integrates the full Phase 5 FMEA, reproducing all 10 failure modes with S/O/D/RPN values and mitigations. The FMEA is explicitly cited as "drawn from Phase 5 FMEA analysis with ADR-level mitigations." Cross-referencing against the Phase 5 evaluation confirms all 10 failure modes are represented.

| FM | Phase 5 RPN | ADR RPN | Match |
|----|-------------|---------|-------|
| FM-007 | 432 | 432 | MATCH |
| FM-001 | 280 | 280 | MATCH |
| FM-003 | 240 | 240 | MATCH |
| FM-002 | 168 | 168 | MATCH |
| FM-005 | 144 | 144 | MATCH |
| FM-010 | 144 | 144 | MATCH |
| FM-006 | 140 | 140 | MATCH |
| FM-009 | 125 | 125 | MATCH |
| FM-004 | 90 | 90 | MATCH |
| FM-008 | 60 | 60 | MATCH |

All RPNs match Phase 5 exactly. FMEA integration is complete and accurate.

**3.2 Risk Mitigations**

Each of the 10 failure modes has an explicit mitigation with phase assignment:

- FM-007 (RPN 432): Mitigation — PR checklist + Phase F perturbation testing. Phase assignment: F (ongoing).
- FM-001 (RPN 280): Mitigation — Position randomization + rubric shuffling. Phase: C.
- FM-003 (RPN 240): Mitigation — 5 universal MRs + workshop + coverage metric. Phase: D.

The mitigation quality is adequate. The ADR correctly identifies FM-007 as "structurally irreducible" (line 474) and does not overclaim that the mitigation eliminates the risk.

**3.3 N >= 20 Sample Size Validation**

**Finding X-1 (Category 2):** The ADR mandates N >= 20 per version for the Wilcoxon signed-rank test (FM-002 mitigation at line 466: "Enforce N >= 20 per version") and the statistical engine code example at line 360-383 assumes paired score arrays. However, the ADR does not specify:

- How the N >= 20 requirement is enforced in the CI/CD pipeline (runtime check vs. configuration constant vs. Phase A acceptance criterion)
- What the fallback behavior is when a test run yields fewer than 20 samples due to timeout or cost constraints in Smoke mode
- Whether the Smoke mode (N=1) is acknowledged as statistically non-valid and how this is communicated to the engineer triggering it

The tiered evaluation modes table (lines 413-419) shows Smoke mode as "N=1 runs per version" but the footnote does not carry the FM-002 risk acknowledgment. An engineer looking at the Smoke mode output will see a report that does not distinguish "statistically valid result" from "single-run snapshot."

**Mitigation documented in ADR:** The tiered modes table and FM-002 mitigation collectively address this, but the communication between the two is not explicit. A Category 2 finding is warranted because the N >= 20 enforcement mechanism is not specified to implementation-ready precision.

**3.4 Residual Risks in Consequences**

The ADR's Negative Consequences section (lines 437-447) documents five negative outcomes, all of which correspond to specific FMEA failure modes:

| Consequence | Corresponding FMEA FM |
|-------------|----------------------|
| Four-layer complexity creates integration risk | FM-001, FM-002, FM-003, FM-009 |
| promptfoo introduces Node.js dependency | FM-004 |
| Metamorphic relation definition requires domain expertise | FM-003 |
| Statistical engine requires N >= 20 | FM-002, FM-006 |
| Time-to-first-value slower than Option A | Explicitly acknowledged |

Residual risk documentation is complete. The ADR does not claim the architecture is risk-free.

### Risk Coverage Check Verdict

CONDITIONAL PASS. One Category 2 finding (N >= 20 enforcement mechanism unspecified). All 10 FMEA failure modes are accurately represented with mitigations. The Category 2 finding has a documented mitigation pathway but requires precision in the implementation plan.

---

## Check 4: Implementation Feasibility

### Finding Summary

**Category 2 (Significant):** The Node.js dependency for promptfoo is managed via Docker/GHA, but the fallback Python API client path is described as "less feature-complete" without specifying which features would be lost and whether the CI/CD gate requirement (M-003) would still be satisfied under the fallback path.

### Analysis

**4.1 Jerry Framework Constraint Compliance**

| Constraint | Source | ADR Compliance | Verdict |
|------------|--------|----------------|---------|
| H-05 UV-only Python execution | CLAUDE.md | ADR explicitly addresses: "DeepEval and statistical engine run via `uv run pytest`; promptfoo runs via Docker/GHA" (line 95). The code examples use `from scipy.stats import wilcoxon` (Python) and standard Python imports. No `npm` or non-UV execution paths appear in the technical implementation for Python components. | PASS |
| H-20 pytest as test runner backbone | quality-enforcement.md | ADR states DeepEval is "a pytest plugin; natural integration" (line 97). The technical implementation section shows standard pytest patterns. | PASS |
| OSI-approved open-source licenses | Phase 5 M-001 | promptfoo (MIT), DeepEval (Apache 2.0), scipy (BSD) — all verified by ADR Evidence Traceability E-013. | PASS |
| CI/CD gate must block merge on regression | Phase 5 M-003 | promptfoo GitHub Action provides merge blocking. pytest exit code provides backup. | PASS |
| Non-determinism-aware assertions | Phase 5 M-004 | Metamorphic relations and statistical tests. Exact-output comparison explicitly excluded. | PASS |

**4.2 Dependency Analysis**

**Finding F-1 (Category 2):** The Node.js/promptfoo dependency is the primary constraint risk. The ADR acknowledges this as FM-004 (RPN 90) with mitigation "Docker image or GitHub Action; Python API client fallback." However, the fallback specification is incomplete:

- The ADR states at line 441: "promptfoo's less feature-complete Python API client" but does not specify which features are absent in the Python client.
- Critical question: Does the Python API client support the before/after diff reporting and GitHub PR block behavior that M-003 requires? If not, the Python fallback does not satisfy the must-criterion.
- The ADR characterizes FM-004 as low severity (RPN 90), which may underweight the risk if the Python fallback cannot satisfy M-003.

This is a Category 2 finding because the primary mitigation path (Docker/GHA) is sound and well-documented, but the fallback path lacks the specificity needed to confirm it satisfies all must-criteria.

**4.3 Phased Roadmap Realism**

| Phase | Estimated Effort | Assessment |
|-------|-----------------|------------|
| A: Foundation | 1-2 weeks | REALISTIC — DeepEval is pytest-native; promptfoo GitHub Action setup is documented; git hash version keys are straightforward. |
| B: Statistical Layer | 1 week | REALISTIC — scipy/statsmodels are well-documented; the Wilcoxon and Wilson implementations are small modules. |
| C: Debiasing | 1-2 days | REALISTIC — Position randomization and rubric shuffling are configuration-level changes to DeepEval. |
| D: Metamorphic | 2-3 weeks for MR definition | REALISTIC but contingent on domain expertise availability. The ADR correctly identifies this as a process risk (FM-003). |
| E: Baseline Quality | 1-2 days | REALISTIC — A quality gate check and CLI audit command are low-complexity additions. |
| F: Coverage | High (ongoing) | APPROPRIATELY LABELED — the ADR does not claim this phase is completable in a fixed timeframe. |

The ADR correctly labels all estimates as "qualitative, derived from component complexity" (line 493). No over-commitment is present. Phase A-B minimum viable harness (2-3 weeks) is credible.

**4.4 Minimum Sample Size Implementation Gap**

(Cross-reference with Check 3, Finding X-1.) The statistical engine's `compare_versions` function in the code example (lines 358-383) takes `scores_a` and `scores_b` as input parameters but does not include an N >= 20 assertion or guard. The runtime enforcement of the minimum sample size is not shown in any code example or configuration specification.

### Implementation Feasibility Check Verdict

CONDITIONAL PASS. Jerry framework constraints are properly addressed for the primary execution path. Two Category 2 findings (F-1 and the cross-cutting N >= 20 enforcement issue from Check 3) require documented resolution before implementation begins. The phased roadmap is realistic for Phases A-D.

---

## Check 5: Interface Compatibility

### Finding Summary

**No Category 1 or Category 2 findings.** Two Category 3 advisory findings.

### Analysis

**5.1 PROJ-017 ADR-002 Alignment**

The ADR devotes an entire L1 section to the PROJ-017 ADR-002 relationship (lines 497-530). The analysis is thorough and structured:

The complementary analysis table (lines 503-510) clearly distinguishes the two ADRs by question type, comparison type, primary concern, promptfoo role, and statistical engine approach. This is a strong interface compatibility analysis.

Shared infrastructure is explicitly identified (lines 511-519):
1. Shared promptfoo installation (coexisting YAML configurations)
2. Shared statistical engine module (`jerry/testing/stats.py`)
3. Shared DeepEval metrics

**5.2 Integration Conflicts**

No integration conflicts were identified. The ADR correctly notes that:
- PROJ-017's BCa bootstrap and PROJ-035's Wilcoxon signed-rank are different statistical methods operating on the same data type (paired score arrays), coexisting in the same module.
- PROJ-017's governance compliance validator is explicitly out of scope for PROJ-035 (line 523).
- PROJ-035's metamorphic relation layer is explicitly not needed for PROJ-017 (line 524).

**Finding I-1 (Category 3):** The sequencing recommendation at line 529 ("Phase A of this ADR's roadmap should be coordinated with PROJ-017's Phase 0 promptfoo trial") is a significant integration dependency that is stated but not operationalized. Specifically:
- PROJ-017 ADR-002 is also in PROPOSED status. If PROJ-017 ADR-002 is rejected or modified, the shared promptfoo infrastructure assumption in PROJ-035 ADR-001 may need revision.
- The ADR does not specify what the PROJ-035 fallback is if PROJ-017 Phase 0 promptfoo trial fails to validate the promptfoo integration assumption.

This is Category 3 because both ADRs are pending human approval simultaneously and the coordination risk is low in practice (both recommend promptfoo), but it is a theoretical sequencing gap.

**5.3 API Boundaries**

The ADR defines the following data exchange boundaries:

| Boundary | Data Contract | Specification Quality |
|----------|--------------|----------------------|
| Layer 1 → Layer 2 | promptfoo passes raw LLM outputs to DeepEval via "custom Python assertion provider" (line 327) | Partially specified — the adapter mechanism is named but not specified to interface level |
| Layer 2 → Layer 4 | DeepEval produces "score arrays" consumed by statistical engine | Adequately specified — `list[float]` type annotations in code example (line 360) |
| Layer 3 → Layer 4 | Metamorphic relations return float scores (0.0 or 1.0) | Adequately specified — `ParaphraseConsistencyMetric.measure()` returns float in code example |
| promptfoo → GitHub PR | Regression report posted to PR | Specified at behavior level ("blocks merge; posts detailed report to PR" at line 318) |

**Finding I-2 (Category 3):** The Layer 1-to-Layer 2 adapter mechanism ("custom Python assertion provider") is the least specified interface in the architecture. The ADR cites Phase 1B as documenting that "a hybrid approach (promptfoo for CI gates, DeepEval for in-depth metric evaluation) is architecturally viable" but does not show the adapter interface definition, data format, or error handling. Phase A implementation will require this to be designed from first principles.

This is Category 3 because the feasibility is established by Phase 1B research and the data direction is clear; the omission is a precision gap for the implementation team, not an architectural ambiguity.

**5.4 Statistical Engine Shared Module**

The proposed `jerry/testing/stats.py` shared module is an important architectural decision made implicitly within the ADR (line 254 and line 517). This shared module serves both PROJ-017 (BCa bootstrap) and PROJ-035 (Wilcoxon signed-rank). The ADR does not address:
- Module ownership (which project owns and tests the shared module)
- Version pinning between projects that share the module
- Whether the shared module requires its own test suite

These are implementation-level concerns that belong in the implementation phase, not in the ADR. The omission is appropriate for an architecture document.

### Interface Compatibility Check Verdict

PASS with two Category 3 advisory findings. No integration conflicts identified with PROJ-017 ADR-002. Shared infrastructure analysis is thorough. Layer boundaries are adequately specified for an architecture decision document.

---

## Exit Criteria Checklist

| # | Exit Criterion | Status | Evidence |
|---|----------------|--------|----------|
| X-1 | All 5 review checks completed with findings documented | PASS | Checks 1-5 complete above |
| X-2 | No Category 1 (blocking) findings remain open | PASS | Zero Category 1 findings identified |
| X-3 | All Category 2 (significant) findings have documented mitigations | CONDITIONAL PASS | Two Category 2 findings identified; both have partial mitigations within the ADR; explicit acknowledgment and resolution path required — see Required Actions |
| X-4 | Review verdict declared | PASS | See Verdict section below |

---

## Finding Register

| # | Category | Check | Finding Summary | Mitigation Status |
|---|----------|-------|-----------------|------------------|
| R-1 | Cat. 3 (Advisory) | Check 1 | Phase 1A-1D quality gate passage not confirmed in ADR | No mitigation needed; advisory only |
| R-2 | Cat. 3 (Advisory) | Check 1 | Sixth-dimension substitution (Time to First Value replacing Evidence Basis) not traced to decision authority | No mitigation needed; advisory only |
| E-1 | Cat. 3 (Advisory) | Check 2 | ADR weighted total (4.45) vs Phase 5 weighted total (4.65) discrepancy partially explained but not fully resolved | ADR line 237 provides partial explanation |
| X-1 | Cat. 2 (Significant) | Check 3 | N >= 20 sample size enforcement mechanism not specified to implementation precision | FM-002 mitigation present; enforcement location unspecified |
| F-1 | Cat. 2 (Significant) | Check 4 | promptfoo Python API fallback path not verified against M-003 (CI/CD gate) must-criterion | FM-004 mitigation present; fallback capability gap unconfirmed |
| I-1 | Cat. 3 (Advisory) | Check 5 | PROJ-017 Phase 0 promptfoo trial coordination — no fallback if trial fails | Sequencing recommendation noted at ADR line 529 |
| I-2 | Cat. 3 (Advisory) | Check 5 | Layer 1-to-Layer 2 adapter interface not specified to implementation level | Phase 1B establishes feasibility; Phase A implementation will define interface |

---

## Verdict

**CONDITIONAL PASS**

ADR-001 is technically sound and ready for human review. The architecture decision is well-grounded, evidence-based, and properly formatted. No Category 1 (blocking) findings were identified.

Two Category 2 findings require acknowledgment and a documented resolution path before Phase A implementation begins. They do not block human review or ADR acceptance, but they must be addressed in the Phase A implementation plan:

1. **Finding X-1:** Specify where and how the N >= 20 minimum sample size is enforced in the pipeline (runtime assertion, configuration schema validation, or CI configuration parameter).

2. **Finding F-1:** Confirm whether promptfoo's Python API client satisfies the M-003 CI/CD gate must-criterion (merge blocking on regression detection). If it does not, document this gap explicitly and identify whether the Docker/GHA primary path is required rather than optional.

The six Category 3 advisory findings are quality improvements that could strengthen the document but do not affect the architectural decision or its implementation viability.

**This verdict is independent of Gate A (adv-scorer quality score). Both gates must pass for the dual quality gate requirement to be satisfied.**

---

## Required Actions

### Category 2 — Required Before Phase A Implementation

| # | Action | Finding | Resolution Path |
|---|--------|---------|-----------------|
| RA-1 | Specify N >= 20 enforcement mechanism: (a) where in the pipeline the check occurs, (b) what the failure mode is when fewer samples are available, and (c) whether Smoke mode output is explicitly labeled "statistically non-valid." | Finding X-1 (Check 3) | Add to Phase A implementation checklist or as a precondition in the ADR L1: Technical Implementation section. Estimated effort: 0.5 days. |
| RA-2 | Confirm or bound the promptfoo Python API client fallback capability: does it support merge-blocking PR status updates (M-003)? Document the answer as a note in the ADR L1: Consequences negative item #2 or in the FM-004 mitigation row. | Finding F-1 (Check 4) | Research promptfoo Python API documentation for CI/CD gate capability. If confirmed: note in ADR. If not confirmed: label Docker/GHA as required (not optional). Estimated effort: 1 day investigation. |

### Category 3 — Recommended Quality Improvements (Not Blocking)

| # | Action | Finding |
|---|--------|---------|
| RA-3 | Confirm in the Evidence Traceability table that Phase 1A-1D research artifacts passed the S-014 quality gate, or add a note referencing the phase-1-scores directory. | Finding R-1 |
| RA-4 | Add a one-sentence justification for the sixth-dimension substitution (Time to First Value for Evidence Basis) citing the architectural decision framework used. | Finding R-2 |
| RA-5 | Add a footnote or note to the Options Comparison Matrix explaining the ADR-to-Phase-5 score translation (why 4.45 and 4.65 are consistent rather than contradictory). | Finding E-1 |
| RA-6 | Add a PROJ-017 dependency note: if PROJ-017 ADR-002 is not accepted, document the PROJ-035 promptfoo setup fallback (standalone setup not dependent on shared infrastructure). | Finding I-1 |

---

## References

- NPR 7123.1D Appendix G, Table G-7 (CDR Entrance Criteria)
- NASA SWEHB 7.9 — Critical Design Review entrance and exit criteria
- Jerry Constitution v1.1 — P-020 (user authority), P-022 (no deception), P-002 (file persistence)
- `projects/PROJ-035-skill-optimization/decisions/ADR-001-test-harness-architecture.md` — Subject of review
- `projects/PROJ-035-skill-optimization/work/EPIC-035-001-test-harnessing/FEAT-035-001-test-harness/FEAT-035-001-test-harness.md` — Acceptance criteria source
- `projects/PROJ-035-skill-optimization/analysis/test-harness-evaluation.md` — Phase 5 FMEA and scoring source
- PROJ-017 ADR-002 (quality-framework-selection) — Interface compatibility reference
- `projects/PROJ-035-skill-optimization/work/test-harness/adv/phase-5-score.md` — Phase 5 quality gate scores

---

*Generated by nse-reviewer agent v1.0.0*
*Review Phase: 8, Gate B (Dual Quality Gate)*
*Date: 2026-03-06*
*PROJ-035 FEAT-035-001*
